Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.
Azitra has raised $31.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.
Azitra's investors include National Science Foundation, Connecticut Innovations, KdT Ventures, National Institutes of Health, U.S. Department of Defense.
Azitra is headquartered in Branford, United States.
Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.
Azitra is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Azitra — Funding & Investors." VCBacked, March 19, 2026, https://www.vcbacked.co/company/azitra. Accessed July 19, 2026.
VCBacked. (2026). Azitra — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/azitra
{{cite web |title=Azitra — Funding & Investors |url=https://www.vcbacked.co/company/azitra |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated